SLC7A11 and lymphoma: Nevertheless, sulphasalazine has been demonstrated to be an effective treatment in cancer models, by inhibiting xCT to activate ferroptosis232,233 and restore sensitivity to chemotherapy.234 Gout et al.235 also reported that targeting xCT with sulphasalazine potently suppresses lymphoma growth.